Here is an article about n-3 fatty acids and asthma from PDR.net:
Kumar A, et al. – In an exploration to shed light on the efficacy of n–3 PUFA in inflammatory diseases, specifically asthma, researchers viewed it as an attractive non–pharmacological intervention which might benefit asthmatics with no major health side effects.
– Based on some evidence from observational and intervention studies, marine-based n-3 PUFA have been proposed as a possible complementary/alternative therapy for asthma
– Altered cell membrane composition might be related to the proposed anti-inflammatory effects of n-3 fatty acids
– Researchers found data highlighting the likely impact of this altered membrane composition following n-3 fatty acid supplementation (primarily EPA and DHA) on modifying lipid mediator generation via the production of eicosanoids with a reduced inflammatory potential/impact
– Researchers have lately identified the significance of a group of lipid mediators derived from EPA including E-series resolvins in the resolution of inflammation
– They acknowledged that reduction in inflammation attenuated the asthma intensity including symptoms (dyspnoea) and exerted a bronchodilatory effect